ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Stock News

USA - NASDAQ:ASBP - US7389201077 - Common Stock

0.3443 USD

+0.01 (+2.47%)

Last: 10/24/2025, 8:09:32 PM

0.3361 USD

-0.01 (-2.38%)

After Hours: 10/24/2025, 8:09:32 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ASBP Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: ACCESS Newswire

Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform

22 days ago - By: ACCESS Newswire

Aspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference - October 8-9, 2025

22 days ago - By: Benzinga - Mentions: CCCC DBVT ACIU CLPT ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

22 days ago - By: Benzinga - Mentions: ZYBT BNAI CIGL AMAT ...

Why Actelis Networks Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket

24 days ago - By: ACCESS Newswire

Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and more-rapid ED medication

a month ago - By: ACCESS Newswire

Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product

a month ago - By: ACCESS Newswire

Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement

2 months ago - By: ACCESS Newswire

Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

2 months ago - By: ACCESS Newswire - Mentions: COE MSGM AIRS IDN ...

Sidoti Events, LLC's Virtual August Micro-Cap Conference